‘Lung capacity down to 50%’, ‘coughing hasn’t stopped for a month’: Smog season worsens woes of ILD patients

This Friday, about 60 patients, mostly women, waited outside the clinic by mid-afternoon, many punctuating the corridor with ...
The American Journal of Managed Care

Anti-Fibrotic Nerandomilast Proves Tolerable Compared With Other IPF/PPF Drugs

Nerandomilast, a novel anti-fibrotic agent with improved tolerability and a dual antifibrotic/immunomodulatory mechanism, ...
Opinion
American Lung AssociationOpinion

National Health and Advocacy Organizations Call on Congress to Include Life-Changing Oxygen Reform in End-of-Year Package

Today, 27 leading patient, provider and professional organizations sent a letter to Congress to include the Supplemental Oxygen Access Reform (SOAR) Act (H.R. 2902/S.1406) in an end-of-year ...

Pulmonary fibrosis traced to key signaling pathway

Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis ...
Frontiers

Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease with a high mortality rate and unclarified aetiology. Immune response is elaborately regulated during the progression of IPF, ...
thorax.bmj

Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study

Background Owing to discrepancies in methodologies and how idiopathic pulmonary fibrosis (IPF) is diagnosed it is challenging to establish a consistent understanding of the disease burden In the UK, ...